Emanuele Cerulli Irelli
Overview
Explore the profile of Emanuele Cerulli Irelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Neurol Ther
. 2025 Mar;
PMID: 40069539
Introduction: Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored...
2.
Cerulli Irelli E, Cocchi E, Gesche J, Pena-Ceballos J, Caraballo R, Lattanzi S, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250354.
PMID: 40063025
Importance: Women with idiopathic generalized epilepsy (IGE) face challenges in treatment due to limited options that are both effective and safe. Objective: To evaluate the effectiveness and safety of substitution...
3.
Assogna M, Di Lorenzo F, Bonni S, Borghi I, Cerulli Irelli E, Mencarelli L, et al.
Brain Commun
. 2025 Mar;
7(2):fcaf080.
PMID: 40046339
Frontotemporal dementia is a devastating neurodegenerative disorder for which no pharmacological treatments have been approved. Neuroinflammation plays a central role in driving the pathogenic mechanisms underlying frontotemporal dementia. In the...
4.
Esposto R, Falcicchio G, Zambrelli E, Cerulli Irelli E, Monti G, Ranzato F, et al.
Epilepsia
. 2025 Jan;
PMID: 39869104
Objective: This study aimed to identify prescribing behaviors in women of childbearing potential (WOCP) with epilepsy already taking valproate (VPA), and to investigate the relationship between VPA maintenance, substitution, reduction,...
5.
Unsupervised clustering of a deeply phenotyped cohort of adults with idiopathic generalized epilepsy
Gavnholt L, Gesche J, Cerulli Irelli E, Kroigard T, Mangaard S, Di Bonaventura C, et al.
Epilepsia
. 2024 Dec;
66(3):700-711.
PMID: 39724391
Objective: Idiopathic generalized epilepsy (IGE) in adults comprise juvenile myoclonic epilepsy (JME), juvenile absence epilepsy (JAE), and epilepsy with generalized tonic-clonic seizures alone (EGTCS), which are defined by their seizure...
6.
Cerulli Irelli E, Fanella M, Chaumette B, Putotto C, Mignot C, Mazzeo A, et al.
Epilepsia
. 2024 Dec;
66(3):859-869.
PMID: 39718534
Objective: This study was undertaken to characterize the clinical and genetic features of patients with 22q11.2 deletion syndrome (22q11.2DS) and generalized epilepsy compared with 22q11.2DS individuals without epilepsy. Methods: This...
7.
Morano A, Cerulli Irelli E, Fortunato F, Casciato S, Panzini C, Milano C, et al.
J Neurol Sci
. 2024 Nov;
467:123288.
PMID: 39546828
Objective: Diagnosing autoimmune limbic encephalitis (ALE) in adults with new-onset seizures can be challenging, especially when seizures represent the predominant manifestation and MRI findings are not straightforward. By comparison with...
8.
Cerulli Irelli E, Mostacci B, Di Bonaventura C
Neurology
. 2024 Oct;
103(10):e209668.
PMID: 39467231
No abstract available.
9.
Moro P, Lattanzi S, Beier C, Di Bonaventura C, Cerulli Irelli E
Epilepsy Behav
. 2024 Aug;
159:109981.
PMID: 39181107
Background: Randomized controlled clinical trials (RCTs) investigating cognitive-behavioral therapy (CBT) among adults with functional seizures (FS) have become increasingly available, prompting the opportunity to critically appraise the efficacy and safety...
10.
Cerulli Irelli E, Cocchi E, Gesche J, Pena-Ceballos J, Caraballo R, Lattanzi S, et al.
Epilepsia
. 2024 Aug;
65(10):2897-2908.
PMID: 39126356
Objective: Women of childbearing age with juvenile absence epilepsy (JAE) face treatment challenges due to limited access to safe and effective anti-seizure medications (ASMs). In a previous study we compared...